Mucus altering agents as adjuncts for nonviral gene transfer to airway epithelium

This publication has 27 references indexed in Scilit:

• Inhibition of recombinant adeno-associated virus (rAAV) transduction by bronchial secretions from cystic fibrosis patients
  Gene Therapy, 2000
• A low rate of cell proliferation and reduced DNA uptake limit cationic lipid-mediated gene transfer to primary cultures of ciliated human airway epithelia
  Gene Therapy, 1997
• ExGen 500 is an efficient vector for gene delivery to lung epithelial cells in vitro and in vivo
  Gene Therapy, 1997
• Efficient in vivo delivery of DNA to pulmonary cells using the novel lipid EDMPC
  Gene Therapy, 1997
• Evidence for safety and efficacy of DOTAP cationic liposome mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis
  Gene Therapy, 1997
• Detailed Analysis of Structures and Formulations of Cationic Lipids for Efficient Gene Transfer to the Lung
  Human Gene Therapy, 1996
• Modification of Nasal Epithelial Potential Differences of Individuals with Cystic Fibrosis Consequent to Local Administration of a Normal CFTR cDNA Adenovirus Gene Transfer Vector
  Human Gene Therapy, 1995
• Improving Access to Intestinal Stem Cells as a Step Toward Intestinal Gene Transfer
  Human Gene Therapy, 1994
• Mucolytic treatment with N-acetylcysteine L-lysinate metered dose inhaler in dogs: airway epithelial function changes
  European Respiratory Journal, 1994
• Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis
  Published by Elsevier ,1993